http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101894066-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101894066-B1 |
| titleOfInvention | Method for Screening Therapeutic Agents against NANOG-mediated Cancer Using HDAC1 and AcH3K14 or AcH3K27 as biomarkers |
| abstract | The present invention relates to a screening method and a diagnostic composition for treating a NANOG-dependent endometriosis cancer, and more particularly, to a method for screening a therapeutic agent by diagnosing a NANOG-dependent or anti-cancer immunostaining cancer by targeting the HDAC1-AcH3K14 / AcH3K27 molecular axis. The screening method and the composition for diagnosing an anticancer agent or an anticancer immuno-tolerant cancer using the molecular axis of the new NANOG-HDAC1-AcH3K14 / AcH3K27 molecule as a pathological marker according to the present invention are more accurate than the anticancer agent or immunotherapy- And is very useful for rapid diagnosis and development of therapeutic agents. |
| priorityDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.